Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma - Sorbonne Université Access content directly
Journal Articles (Data Paper) Nature Communications Year : 2023

Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma

Abstract

Abstract Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, yet it remains refractory to systemic therapy. Elimination of senescent cells has emerged as a promising new treatment approach against cancer. Here, we investigated the contribution of senescent cells to GBM progression. Senescent cells are identified in patient and mouse GBMs. Partial removal of p16 Ink4a -expressing malignant senescent cells, which make up less than 7 % of the tumor, modifies the tumor ecosystem and improves the survival of GBM-bearing female mice. By combining single cell and bulk RNA sequencing, immunohistochemistry and genetic knockdowns, we identify the NRF2 transcription factor as a determinant of the senescent phenotype. Remarkably, our mouse senescent transcriptional signature and underlying mechanisms of senescence are conserved in patient GBMs, in whom higher senescence scores correlate with shorter survival times. These findings suggest that senolytic drug therapy may be a beneficial adjuvant therapy for patients with GBM.
Fichier principal
Vignette du fichier
s41467-023-36124-9.pdf (9.2 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Licence : CC BY - Attribution

Dates and versions

hal-03969354 , version 1 (21-11-2022)
hal-03969354 , version 2 (12-09-2023)

Identifiers

Cite

Rana Salam, Alexa Saliou, Franck Bielle, Mathilde Bertrand, Christophe Antoniewski, et al.. Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma. Nature Communications, 2023, 14 (1), pp.441. ⟨10.1038/s41467-023-36124-9⟩. ⟨hal-03969354v2⟩
48 View
14 Download

Altmetric

Share

Gmail Facebook X LinkedIn More